Gene · 5539
NIH grants1,759
NIH grants whose papers are about the gene, through NIH's grant-paper links.
381 to 400 of 1,759
Download this page as JSON| Grant | Title | PPY papers | Newest fiscal year |
|---|---|---|---|
| R01DK055758 | Adiponectin, A Protein Secreted From Adipose Tissue | 1 | 2024 |
| R01DK057539 | Role of Forkhead proteins in insulin action | 1 | 2024 |
| R01DK058538 | Selenodeidinase Processing by the Proteasome System | 1 | 2024 |
| R01DK066485 | Structural basis of KATP channel gating | 1 | 2024 |
| R01DK072193 | Targeted Genetic Analysis of T2D and Quantitative Traits | 1 | 2024 |
| R01DK081166 | Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells | 1 | 2024 |
| R01DK097830 | Evaluation of the entero-insular (incretin) axis in cystic fibrosis-competitive renewal. | 1 | 2024 |
| R01DK101530 | Leveraging the Uniquely High Beta-Cell Zinc Content for Targeted Drug Delivery | 1 | 2024 |
| R01DK103831 | Tuft cell heterogeneity in function, lineage, and structure in ileal inflammatory disease | 1 | 2024 |
| R01DK104942 | Monogenic Diabetes: Next Generation Diagnosis, Treatment and Complications | 1 | 2024 |
| R01DK121929 | Beta cell extracellular vesicles in health and disease | 1 | 2024 |
| R01DK121987 | Exocrine-Endocrine Crosstalk and Determinants of Beta Cell Growth | 1 | 2024 |
| R01DK123329 | Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes | 1 | 2024 |
| R01DK124527 | The delta cell as a key regulator of pancreatic islet biology | 1 | 2024 |
| R01DK125353 | Novel metabolic actions of GIP | 1 | 2024 |
| R01DK125680 | A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanisms | 1 | 2024 |
| R01DK126444 | iPLA2beta-mediated alternative splicing and beta-cell death in type 1 diabetes | 1 | 2024 |
| R01DK128932 | Genetic and physiologic regulation of pig islet development and function | 1 | 2024 |
| R01DK129464 | Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes | 1 | 2024 |
| R01ES023316 | Chromatin contacts are germline-transmissable vehicles underlying epigenetic transgenerational inheritance | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5539/grants?page=20